TNX-102 SL Tablet
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TNX-102 SL Tablet, covering 2025-02-25 to 2025-02-25. Get the full timeline:
Most recent: Clinical Trial Update: Repeat of: A Study to Evaluate Efficacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With Fibromyalgia [Phase 3]